Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has earned an average rating of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price target among […]
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among […]
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) and Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Volatility and Risk Takeda Pharmaceutical has a beta […]
Codexis, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.16.
REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Codexis Inc. (CDXS) on Wednesday reported a loss of $7.2 million in its fourth quarter.